AAN/AES Guideline: SUDEP Incidence & Risk Factors (2017)
This topic summarizes the 2017 AAN/AES practice guideline on sudden unexpected death in epilepsy (SUDEP), addressing incidence rates across populations and established risk factors based on class I and II evidence.
🔹 Bottom Line
- Guideline: AAN/AES 2017 practice guideline — 12 class I studies for incidence; 6 class I + 16 class II for risk factors
- Incidence: Children 0.22/1,000 patient-years (1 in 4,500/yr); Adults 1.2/1,000 patient-years (1 in 1,000/yr)
- #1 risk factor: GTCS — presence gives 10× risk; ≥3 GTCS/yr gives 15× risk (high confidence)
- Risk reduction: Nocturnal supervision (OR 0.4) and listening devices (OR 0.1) decrease SUDEP risk
- Seizure freedom, especially from GTCS, is strongly associated with decreased SUDEP risk (Level B)
- Counseling: Clinicians should inform all patients/families about SUDEP risk (Level B)
- No specific AED is associated with increased SUDEP risk — uncontrolled GTCS is the driver
Guideline Overview
Source & Scope
- Organizations: AAN Guideline Development, Dissemination, and Implementation Subcommittee + AES Guidelines Committee
- Published: Epilepsy Currents, Vol. 17, No. 3, May/June 2017
- Authors: Harden C, Tomson T, Gloss D, Buchhalter J, Cross JH, Donner E, et al.
- Evidence base: 12 class I studies (incidence); 6 class I + 16 class II articles (risk factors)
- Two questions addressed:
- What is the incidence of SUDEP in different epilepsy populations?
- Are there specific risk factors for SUDEP?
SUDEP Definition (Nashef 1997 Criteria)
- Patient had epilepsy by reasonable criteria
- Death by drowning, trauma, or status epilepticus excluded
- Death could have occurred after a witnessed seizure
- Other competing causes of death excluded
Q1: SUDEP Incidence Rates
| Population | SUDEP per 1,000 Patient-Years (95% CI) | Practical Framing | Confidence |
|---|---|---|---|
| Overall | 0.58 (0.31–1.08) | — | Low |
| Children (0–17 yr) | 0.22 (0.16–0.31) | 1 in 4,500 children/yr | Moderate |
| Adults | 1.2 (0.64–2.32) | 1 in 1,000 adults/yr | Low |
- Significant unexplained heterogeneity across studies — suggests unknown/unexplored risk factors
- SUDEP risk increases from childhood to adulthood
- Refractory epilepsy populations have higher rates (up to 18/1,000 patient-years with frequent GTCS)
Counseling Framing (Guideline-Recommended)
- Children: “SUDEP typically affects 1 in 4,500 children with epilepsy per year; 4,499 of 4,500 will NOT be affected”
- Adults: “SUDEP typically affects 1 in 1,000 adults with epilepsy per year; 999 of 1,000 will NOT be affected”
- Present both the risk AND the probability of NOT being affected — reduces overestimation and anxiety
- Use numbers and frequencies rather than percentages alone
🔹 Clinical Pearl
The guideline recommends framing SUDEP risk with BOTH the probability of having AND not having the event. This dual framing reduces anxiety without minimizing risk. Patients and families prefer to be informed even when the probability is low.
Q2: SUDEP Risk Factors
Established Risk Factors
| Factor | Odds Ratio (95% CI) | Confidence |
|---|---|---|
| Presence of GTCS (vs no GTCS) | 10 (17–14) | Moderate |
| GTCS frequency: 1–2/yr | 5.07 (2.94–8.76) | High |
| GTCS frequency: ≥3/yr | 15.46 (9.92–24.10) | High |
| Not seizure-free for 1–5 yr | 4.7 (1.4–16) | Moderate |
| Not adding AED when refractory | 6 (2–20) | Moderate |
Protective Factors
| Factor | Odds Ratio (95% CI) | Confidence |
|---|---|---|
| Nocturnal supervision (bedroom observer ≥10 yr, normal intelligence) | 0.4 (0.2–0.8) | Moderate |
| Nocturnal listening device | 0.1 (0–0.3) | Moderate |
Factors Associated with SUDEP (Low/Conflicting Evidence)
- Nocturnal seizures (increased risk)
- Extratemporal epilepsy (increased risk)
- Intellectual disability (increased risk)
- Male gender (increased risk)
- Anxiolytic drug use (increased risk)
- Number of AEDs used overall (increased risk — likely a proxy for refractory epilepsy)
- Never having been treated with an AED (increased risk)
- Lamotrigine use in women (increased risk — conflicting)
Factors NOT Clearly Associated with SUDEP
- No specific AED is associated with increased SUDEP risk
- Overall seizure frequency (all seizure types combined)
- Medically refractory epilepsy (defined as uncontrolled non-GTCS seizures)
- Monotherapy vs polytherapy
- Specific AED levels (CBZ, PHT, VPA) above/below/within range
- Heart rate variability
- Psychotropic drug use, mental health disorders, alcohol use
- Epilepsy surgery or Engel outcome
- VNS use >2 years
- Epilepsy etiology, structural lesion on MRI
- Duration of epilepsy, age at epilepsy onset
- Postictal EEG suppression
🔹 Clinical Pearl
GTCS frequency is the #1 modifiable risk factor for SUDEP (high confidence, OR 15.46 for ≥3 GTCS/yr). GTCS are not just associated with SUDEP — MORTEMUS data shows GTCS was always the precipitating event, suggesting GTCS is in the causal pathway to SUDEP. Reducing GTCS = reducing SUDEP risk.
Recommendations
| # | Recommendation | Level | Key Details |
|---|---|---|---|
| 1 | Inform parents/guardians of children about SUDEP | B | SUDEP is rare; 1 in 4,500 children/yr; 4,499 will not be affected |
| 2 | Inform adult patients about SUDEP | B | Small risk; 1 in 1,000 adults/yr; 999 will not be affected |
| 3 | Actively manage epilepsy to reduce GTCS and SUDEP risk | B | Incorporate patient preferences; weigh risks/benefits of new therapies |
| 4 | Consider nocturnal supervision or listening device for high-risk patients | C | For patients with frequent GTCS + nocturnal seizures; balance with intrusiveness |
| 5 | Inform patients that seizure freedom decreases SUDEP risk | B | Freedom from GTCS (via medication adherence) is strongly protective |
Practical Counseling Points
- Discuss SUDEP at diagnosis or soon after — patients and families prefer to be informed
- Emphasize that SUDEP risk is modifiable through seizure control
- Therapy adherence is crucial — GTCS freedom through medication compliance reduces risk
- For patients with uncontrolled GTCS: optimize ASM therapy, consider adding medications
- Nocturnal precautions for high-risk patients: bedroom observer, listening devices, seizure detection alarms
- Present risk using both the probability of the event AND the probability of NOT having the event
MORTEMUS Study & Mechanism
- MORTEMUS (Ryvlin et al, Lancet Neurol 2013): Retrospective analysis of cardiorespiratory arrests in epilepsy monitoring units
- All SUDEP cases were preceded by a GTCS — no SUDEP without preceding GTCS in this cohort
- Sequence: GTCS → postictal generalized EEG suppression (PGES) → central apnea → terminal cardiac arrest
- Median time from seizure end to terminal apnea: ~3 min
- Postictal respiratory depression is the primary mechanism — supports the causal role of GTCS
- This strongly suggests that controlling GTCS directly prevents SUDEP
🔹 Clinical Pearl
Key numbers for boards: SUDEP incidence = 0.22/1,000 pt-yr in children (1 in 4,500), 1.2/1,000 pt-yr in adults (1 in 1,000). The #1 risk factor is GTCS frequency (OR 15.46 for ≥3/yr). Nocturnal listening devices are the strongest protective factor (OR 0.1). All 5 recommendations are Level B or C — no Level A recommendations exist for SUDEP counseling.